These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1108 related articles for article (PubMed ID: 2351486)

  • 21. Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage.
    Katz BZ; Ishai-Michaeli R; Zusman T; Vlodavsky I; Witz IP
    Invasion Metastasis; 1994-1995; 14(1-6):276-89. PubMed ID: 7657521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
    Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
    Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A solid-phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity.
    Nakajima M; Irimura T; Nicolson GL
    Anal Biochem; 1986 Aug; 157(1):162-71. PubMed ID: 3766958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.
    Marchetti D; Li J; Shen R
    Cancer Res; 2000 Sep; 60(17):4767-70. PubMed ID: 10987284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis.
    Nasser NJ; Avivi A; Shafat I; Edovitsky E; Zcharia E; Ilan N; Vlodavsky I; Nevo E
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2253-8. PubMed ID: 19164514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
    Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
    Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic significance of heparanase expression in metastatic melanoma.
    Vornicova O; Boyango I; Feld S; Naroditsky I; Kazarin O; Zohar Y; Tiram Y; Ilan N; Ben-Izhak O; Vlodavsky I; Bar-Sela G
    Oncotarget; 2016 Nov; 7(46):74678-74685. PubMed ID: 27732945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils.
    Mollinedo F; Nakajima M; Llorens A; Barbosa E; Callejo S; Gajate C; Fabra A
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):917-23. PubMed ID: 9581574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
    Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
    Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.
    Goldshmidt O; Zcharia E; Abramovitch R; Metzger S; Aingorn H; Friedmann Y; Schirrmacher V; Mitrani E; Vlodavsky I
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10031-6. PubMed ID: 12097647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of heparanase in glioblastoma multiforme.
    Ueno Y; Yamamoto M; Vlodavsky I; Pecker I; Ohshima K; Fukushima T
    J Neurosurg; 2005 Mar; 102(3):513-21. PubMed ID: 15796387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the heparanase enzymes from mouse melanoma cells, mouse macrophages, and human platelets.
    Graham LD; Underwood PA
    Biochem Mol Biol Int; 1996 Jun; 39(3):563-71. PubMed ID: 8828808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation of basement membrane by prostate tumor heparanase.
    Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
    J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective heparanase localization in malignant melanoma.
    Murry BP; Greiter-Wilke A; Paulsen DP; Hiatt KM; Beltrami CA; Marchetti D
    Int J Oncol; 2005 Feb; 26(2):345-52. PubMed ID: 15645118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human prostate carcinoma cells produce extracellular heparanase.
    Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
    J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparanase expression and localization in different types of human lung cancer.
    Fernandes dos Santos TC; Gomes AM; Paschoal ME; Stelling MP; Rumjanek VM; Junior Ado R; Valiante PM; Madi K; Pereira de Souza HS; Pavão MS; Castelo-Branco MT
    Biochim Biophys Acta; 2014 Aug; 1840(8):2599-608. PubMed ID: 24747732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
    Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
    J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
    Rozhin J; Robinson D; Stevens MA; Lah TT; Honn KV; Ryan RE; Sloane BF
    Cancer Res; 1987 Dec; 47(24 Pt 1):6620-8. PubMed ID: 2824039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparanase is overexpressed in lung cancer and correlates inversely with patient survival.
    Cohen E; Doweck I; Naroditsky I; Ben-Izhak O; Kremer R; Best LA; Vlodavsky I; Ilan N
    Cancer; 2008 Sep; 113(5):1004-11. PubMed ID: 18618498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.